Structural, functional and biological insights into the role of Mycobacterium tuberculosis VapBC11 toxin–antitoxin system: targeting a tRNase to tackle mycobacterial adaptation

Abstract Toxin–antitoxin (TA) systems are involved in diverse physiological processes in prokaryotes, but their exact role in Mycobacterium tuberculosis (Mtb) virulence and in vivo stress adaptation has not been extensively studied. Here, we demonstrate that the VapBC11 TA module is essential for Mtb to establish infection in guinea pigs. RNA-sequencing revealed that overexpression of VapC11 toxin results in metabolic slowdown, suggesting that modulation of the growth rate is an essential strategy for in vivo survival. Interestingly, overexpression of VapC11 resulted in the upregulation of chromosomal TA genes, suggesting the existence of highly coordinated crosstalk among TA systems. In this study, we also present the crystal structure of the VapBC11 heterooctameric complex at 1.67 Å resolution. Binding kinetic studies suggest that the binding affinities of toxin–substrate and toxin–antitoxin interactions are comparable. We used a combination of structural studies, molecular docking, mutational analysis and in vitro ribonuclease assays to enhance our understanding of the mode of substrate recognition by the VapC11 toxin. Furthermore, we have also designed peptide-based inhibitors to target VapC11 ribonuclease activity. Taken together, we propose that the structure-guided design of inhibitors against in vivo essential ribonucleases might be a novel strategy to hasten clearance of intracellular Mtb.

[1]  H. Mutschler,et al.  ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development , 2011, Journal of Molecular Medicine.

[2]  K. Gerdes,et al.  Prokaryotic toxin–antitoxin stress response loci , 2005, Nature Reviews Microbiology.

[3]  I. Smith,et al.  Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response. , 2008, The Journal of infectious diseases.

[4]  P. Tiwari,et al.  Polyphosphate Deficiency in Mycobacterium tuberculosis Is Associated with Enhanced Drug Susceptibility and Impaired Growth in Guinea Pigs , 2013, Journal of bacteriology.

[5]  Nicholas M. Luscombe,et al.  Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..

[6]  J. Betts,et al.  Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling , 2002, Molecular microbiology.

[7]  Madavan Vasudevan,et al.  Co-expression network analysis of toxin-antitoxin loci in Mycobacterium tuberculosis reveals key modulators of cellular stress , 2017, Scientific Reports.

[8]  Ramandeep Singh,et al.  The Three RelE Homologs of Mycobacterium tuberculosis Have Individual, Drug-Specific Effects on Bacterial Antibiotic Tolerance , 2010, Journal of bacteriology.

[9]  H. Munro The determination of nucleic acids. , 2006, Methods of biochemical analysis.

[10]  J. Butler,et al.  Analysis of Non-Typeable Haemophilous influenzae VapC1 Mutations Reveals Structural Features Required for Toxicity and Flexibility in the Active Site , 2014, PloS one.

[11]  E. Rubin,et al.  Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters , 2011, mBio.

[12]  V. Arcus,et al.  The PIN-domain ribonucleases and the prokaryotic VapBC toxin-antitoxin array. , 2011, Protein engineering, design & selection : PEDS.

[13]  M. Tameris,et al.  First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. , 2015, Vaccine.

[14]  S. Darst,et al.  Effects of Increasing the Affinity of CarD for RNA Polymerase on Mycobacterium tuberculosis Growth, rRNA Transcription, and Virulence , 2016, Journal of bacteriology.

[15]  Markus Sköld,et al.  Tuberculosis and HIV Co-Infection , 2012, PLoS pathogens.

[16]  Yang Liu,et al.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages , 2003, The Journal of experimental medicine.

[17]  D. Brodersen,et al.  Structural conservation of the PIN domain active site across all domains of life , 2017, Protein science : a publication of the Protein Society.

[18]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[19]  D. Eisenberg,et al.  Structure and Proposed Activity of a Member of the VapBC Family of Toxin-Antitoxin Systems , 2009, Journal of Biological Chemistry.

[20]  O. Strausz,et al.  Kinetics of the , 1967 .

[21]  Jonathan W. Cruz,et al.  Growth-regulating Mycobacterium tuberculosis VapC-mt4 toxin is an isoacceptor-specific tRNase , 2015, Nature Communications.

[22]  E. Koonin,et al.  Comprehensive comparative-genomic analysis of Type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes , 2009, Biology Direct.

[23]  P. Tiwari,et al.  System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis , 2018, The Journal of infectious diseases.

[24]  Wilfried Rozhon,et al.  Toxin–antitoxin systems , 2013, Mobile genetic elements.

[25]  K. Gerdes,et al.  Retraction Notice to: (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity , 2018, Cell.

[26]  R. Brennan,et al.  Structure of FitAB from Neisseria gonorrhoeae Bound to DNA Reveals a Tetramer of Toxin-Antitoxin Heterodimers Containing Pin Domains and Ribbon-Helix-Helix Motifs* , 2006, Journal of Biological Chemistry.

[27]  P. Tiwari,et al.  MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs , 2015, Nature Communications.

[28]  H. Dockrell Towards new TB vaccines: What are the challenges? , 2016, Pathogens and disease.

[29]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[30]  Liisa Holm,et al.  Dali server: conservation mapping in 3D , 2010, Nucleic Acids Res..

[31]  Rick Lyons,et al.  The temporal expression profile of Mycobacterium tuberculosis infection in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  V. Molle,et al.  Bacterial Serine/Threonine Protein Kinases in Host-Pathogen Interactions* , 2014, The Journal of Biological Chemistry.

[33]  Tige R. Rustad,et al.  The Enduring Hypoxic Response of Mycobacterium tuberculosis , 2008, PloS one.

[34]  P. Genevaux,et al.  Multiple Toxin-Antitoxin Systems in Mycobacterium tuberculosis , 2014, Toxins.

[35]  Rebecca Page,et al.  Toxin-antitoxin systems in bacterial growth arrest and persistence. , 2016, Nature chemical biology.

[36]  D. Tollervey,et al.  VapCs of Mycobacterium tuberculosis cleave RNAs essential for translation , 2016, Nucleic Acids Research.

[37]  Raphaël Leplae,et al.  Diversity of bacterial type II toxin–antitoxin systems: a comprehensive search and functional analysis of novel families , 2011, Nucleic acids research.

[38]  D. Eisenberg,et al.  The crystal structure of the Rv0301‐Rv0300 VapBC‐3 toxin—antitoxin complex from M. tuberculosis reveals a Mg2+ ion in the active site and a putative RNA‐binding site , 2012, Protein science : a publication of the Protein Society.

[39]  M. Wilmanns,et al.  Crystal structure of the VapBC-15 complex from Mycobacterium tuberculosis reveals a two-metal ion dependent PIN-domain ribonuclease and a variable mode of toxin-antitoxin assembly. , 2014, Journal of structural biology.

[40]  W. Jacobs,et al.  Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. , 2002, Microbiology.

[41]  P. Schuck,et al.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.

[42]  Kiyoung Lee,et al.  Structural and functional studies of the Mycobacterium tuberculosis VapBC30 toxin-antitoxin system: implications for the design of novel antimicrobial peptides , 2015, Nucleic acids research.

[43]  L. Buts,et al.  Escherichia coli antitoxin MazE as transcription factor: insights into MazE-DNA binding , 2015, Nucleic acids research.

[44]  Owen Johnson,et al.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.

[45]  Vineet Kumar,et al.  Novel MntR-Independent Mechanism of Manganese Homeostasis in Escherichia coli by the Ribosome-Associated Protein HflX , 2014, Journal of bacteriology.

[46]  K. Gerdes,et al.  RETRACTED: (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity , 2013, Cell.

[47]  J. Perona,et al.  Kinetics of tRNA Folding Monitored by Aminoacylation , 2012, RNA.

[48]  R. Slayden,et al.  Toxin-antitoxin systems and regulatory mechanisms in Mycobacterium tuberculosis. , 2018, Pathogens and disease.

[49]  J. Butler,et al.  Structural Determinants for Antitoxin Identity and Insulation of Cross Talk between Homologous Toxin-Antitoxin Systems , 2016, Journal of bacteriology.

[50]  V. Arcus,et al.  Determination of ribonuclease sequence-specificity using Pentaprobes and mass spectrometry. , 2012, RNA.

[51]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[52]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[53]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[54]  Christian N. S. Pedersen,et al.  Toxin inhibition in C. crescentus VapBC1 is mediated by a flexible pseudo-palindromic protein motif and modulated by DNA binding , 2016, Nucleic acids research.

[55]  Soni Kaundal,et al.  Crystal structure of Mycobacterium tuberculosis VapC20 toxin and its interactions with cognate antitoxin, VapB20, suggest a model for toxin–antitoxin assembly , 2017, The FEBS journal.

[56]  D. Brodersen,et al.  Higher-Order Structure in Bacterial VapBC Toxin-Antitoxin Complexes. , 2017, Sub-cellular biochemistry.

[57]  C. Dienemann,et al.  Crystal Structure of the VapBC Toxin–Antitoxin Complex from Shigella flexneri Reveals a Hetero-Octameric DNA-Binding Assembly , 2011, Journal of molecular biology.

[58]  Alimuddin Zumla,et al.  The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. , 2018, The Lancet. Respiratory medicine.

[59]  Zhidong Liu,et al.  Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level , 2016, Scientific Reports.

[60]  D. Brodersen,et al.  VapC20 of Mycobacterium tuberculosis cleaves the Sarcin–Ricin loop of 23S rRNA , 2013, Nature Communications.

[61]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[62]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[63]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[64]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[65]  H. Yoon,et al.  Functional details of the Mycobacterium tuberculosis VapBC26 toxin-antitoxin system based on a structural study: insights into unique binding and antibiotic peptides , 2017, Nucleic acids research.

[66]  P. Hergenrother,et al.  Artificial activation of toxin-antitoxin systems as an antibacterial strategy. , 2012, Trends in microbiology.

[67]  K. Gerdes,et al.  Regulation of Enteric vapBC Transcription: Induction by VapC Toxin Dimer-Breaking , 2012, Nucleic acids research.

[68]  B. Devreese,et al.  Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity. , 2014, Pathogens and disease.

[69]  G. Schoolnik,et al.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. , 2004, Tuberculosis.

[70]  G. N. Ramachandran,et al.  Stereochemistry of polypeptide chain configurations. , 1963, Journal of molecular biology.

[71]  S. Kaufmann,et al.  Mycobacterium tuberculosis: success through dormancy. , 2012, FEMS microbiology reviews.

[72]  Pei Zhou,et al.  HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy , 2017, Nucleic Acids Res..

[73]  S. Borrell,et al.  Strain Diversity and the Evolution of Antibiotic Resistance. , 2017, Advances in experimental medicine and biology.

[74]  S. M. de Freitas,et al.  Crystal structure of VapC21 from Mycobacterium tuberculosis at 1.31 Å resolution. , 2016, Biochemical and biophysical research communications.

[75]  K. Gerdes,et al.  Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins , 2002, Molecular microbiology.

[76]  A. Kaprelyants,et al.  Toxin-antitoxin vapBC locus participates in formation of the dormant state in Mycobacterium smegmatis. , 2014, FEMS microbiology letters.